These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oncogene addiction. Weinstein IB; Joe A Cancer Res; 2008 May; 68(9):3077-80; discussion 3080. PubMed ID: 18451130 [TBL] [Abstract][Full Text] [Related]
23. Oncogene addiction: role of signal attenuation. Hübner A; Jaeschke A; Davis RJ Dev Cell; 2006 Dec; 11(6):752-4. PubMed ID: 17141149 [TBL] [Abstract][Full Text] [Related]
25. [The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras]. Pospelova TV; Kisliakova TV; Medvedev AV; Svetlikova SB; Pospelov VA Tsitologiia; 1990; 32(2):148-55. PubMed ID: 2142348 [TBL] [Abstract][Full Text] [Related]
27. Growth control and neoplastic transformation in the brain. Wiestler OD; Herrlich P Cancer Cells; 1991 Sep; 3(9):355-8. PubMed ID: 1684281 [TBL] [Abstract][Full Text] [Related]
28. [Better understanding of the biology of cancer cells]. Klein G Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045 [TBL] [Abstract][Full Text] [Related]
29. Multiphasity of neoplastic induction. Parodi S; Taningher M Eur J Cancer Prev; 1996 Oct; 5(5):368-70. PubMed ID: 8972257 [No Abstract] [Full Text] [Related]
30. [Intervening factors in the carcinogenesis]. Bay ML; Morini JC Medicina (B Aires); 1990; 50(3):259-62. PubMed ID: 2130214 [No Abstract] [Full Text] [Related]
31. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages. Banks L; Moreau F; Vousden K; Pim D; Matlashewski G J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576 [TBL] [Abstract][Full Text] [Related]
32. Molecular probes in neuro-oncology: a review. Rutka JT; Trent JM; Rosenblum ML Cancer Invest; 1990; 8(3-4):425-38. PubMed ID: 2169969 [No Abstract] [Full Text] [Related]
33. Molecular mechanisms of transformation by the v-rel oncogene. Hannink M; Temin HM Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Spandidos DA Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595 [TBL] [Abstract][Full Text] [Related]
36. Oncogene-induced transcriptional patterns in established cell lines as a model for in vitro analysis of tumor biology. Careta Fde P; Azevedo BM; Vianna BA; Paneto GG; Degasperi II; Oyama Mdo C; Fagundes V; Perrone AM; Louro ID Genet Mol Res; 2004 Sep; 3(3):410-20. PubMed ID: 15614731 [TBL] [Abstract][Full Text] [Related]
37. [Studies of growth, differentiation and neoplastic transformation of human and animal cells--views and trends:1985-1988]. Korohoda W Postepy Biochem; 1988; 34(4):269-71. PubMed ID: 3077652 [No Abstract] [Full Text] [Related]
38. Immortalization as an endpoint in studies on malignant transformation. Simons JW; Bols BL; Naaktgeboren JM Prog Clin Biol Res; 1990; 340D():207-17. PubMed ID: 2196580 [No Abstract] [Full Text] [Related]
39. Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling. Minamoto T; Ougolkov AV; Mai M Expert Rev Mol Diagn; 2002 Nov; 2(6):565-75. PubMed ID: 12465453 [TBL] [Abstract][Full Text] [Related]
40. ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf. Mercer K; Chiloeches A; Hüser M; Kiernan M; Marais R; Pritchard C Oncogene; 2002 Jan; 21(3):347-55. PubMed ID: 11821947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]